Literature DB >> 1382911

Predominant usage of V beta 8.3 T cell receptor in a T cell line that induces experimental autoimmune uveoretinitis (EAU).

C E Egwuagu1, S Bahmanyar, R M Mahdi, R B Nussenblatt, I Gery, R R Caspi.   

Abstract

Experimental autoimmune uveoretinitis (EAU) is a T cell-mediated autoimmune disease induced in animals by immunization with retinal proteins (or synthetic fragments derived from them) in adjuvant, and it is considered a model of human autoimmune diseases of the eye. To study the T cell clonotypes that may be involved in EAU, we analyzed the T cell repertoire of three related T cell lines: the pathogenic line LR16, specific to the major uveitogenic epitope of IRBP; its pathogenic subline J; and its nonpathogenic subline A. We examined the expression of the genes coding for the variable regions of the 20 known Lewis rat T cell antigen receptor (TCR) V beta families. The nonpathogenic subline was found to contain mostly T cells expressing V beta 5, V beta 8.2, and V beta 19 while the pathogenic subline consisted mainly of cells expressing V beta 8.3 TCRs. Genomic Southern blot analysis of DNA from the pathogenic subline showed that V beta 8.3-expressing T cells were the dominant clonotype, and DNA sequence analyses of V beta 8.3 cDNAs revealed that two V beta 8.3 TCRs were expressed in the pathogenic subline. One of the V beta 8.3 cDNAs encoded a variable region gene segment identical to previously reported rat V beta 8.3 TCR while the other differed by two amino acids in the second complementarity determining region (CDR2). Taken together with previous data showing overrepresentation of V beta 8-expression in T cell lines that induce EAU, but not in nonuveitogenic T cell lines, our results suggest that V beta 8.3-expressing T cells represent a pathogenic clonotype in IRBP-induced EAU.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382911     DOI: 10.1016/0090-1229(92)90218-d

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  7 in total

1.  The role of CD44 in cutaneous inflammation.

Authors:  Mona Man; Peter M Elias; Wenyan Man; Yan Wu; Lilly Y W Bourguignon; Kenneth R Feingold; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2009-03-26       Impact factor: 3.960

2.  HMGB1 is an early and critical mediator in an animal model of uveitis induced by IRBP-specific T cells.

Authors:  Guomin Jiang; Deming Sun; Huan Yang; Qingxian Lu; Henry J Kaplan; Hui Shao
Journal:  J Leukoc Biol       Date:  2013-12-27       Impact factor: 4.962

3.  Neuritogenic Lewis rat T cells use Tcrb chains that include a new Tcrb-V8 family member.

Authors:  X M Zhang; T R Esch; L Clark; S Gregorian; A Rostami; L Otvos; E Heber-Katz
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

4.  Damage-associated Molecular Patterns in Clinical and Animal Models of Uveitis.

Authors:  Henry J Kaplan; Deming Sun; Hui Shao
Journal:  Ocul Immunol Inflamm       Date:  2021-09-03       Impact factor: 3.728

5.  HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas/FasL activation-dependent.

Authors:  Guomin Jiang; Yunsong Wang; Juan Yun; Amir Reza Hajrasouliha; Yuan Zhao; Deming Sun; Henry J Kaplan; Hui Shao
Journal:  J Neuroinflammation       Date:  2015-09-22       Impact factor: 8.322

6.  The HMGB1-CXCL12 Complex Promotes Inflammatory Cell Infiltration in Uveitogenic T Cell-Induced Chronic Experimental Autoimmune Uveitis.

Authors:  Juan Yun; Guomin Jiang; Yunsong Wang; Tong Xiao; Yuan Zhao; Deming Sun; Henry J Kaplan; Hui Shao
Journal:  Front Immunol       Date:  2017-02-14       Impact factor: 7.561

7.  Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity.

Authors:  Rafael S Grajewski; Phyllis B Silver; Rajeev K Agarwal; Shao-Bo Su; Chi-Chao Chan; Gregory I Liou; Rachel R Caspi
Journal:  J Exp Med       Date:  2006-04-03       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.